Series A Funding Completed by Noro-Moseley Partners
Nashville, TN — (BUSINESS WIRE) – Trilliant Health, an analytics company that empowers healthcare providers to create and execute data-driven strategies to maximize revenue and market share growth, today announced they have completed their Series A financing of over $12 million, consisting of more than $7 million of new equity capital, led by Noro-Moseley Partners, with participation from existing investors Martin Ventures, Nashville Capital Network, and NueCura Partners.
Trilliant Health will use the funding to continue building its data science and technology teams to enhance the capabilities of its analytics platform. The Trilliant analytics platform uses advanced data science to combine claims data, household data, and user-generated data from digital marketing campaigns to support healthcare systems around strategy, site selection, M&A, payer negotiations, physician relationship management, marketing, and employer relationship management. Today, the company works with over 60 healthcare systems across the nation to build and execute on their growth strategies.
“Trilliant Health turns analytics into highly differentiated insights and intelligence to help healthcare providers better understand their individual market dynamics,” said Spence McClelland, General Partner at Noro-Moseley Partners. “The Trilliant leadership team and investor group have some of the strongest backgrounds and expertise in healthcare. This healthcare experience, combined with the deep bench of data science, technology, and product teams, positions Trilliant to transform the way healthcare systems approach growth. If I were a healthcare system executive needing to grow revenue and market share, I would seek a trusted advisor that has a proven track record.”
“While the data science may be complex, the strategy isn’t. Hospitals and ambulatory centers need patients. Patients need care. Trilliant helps hospitals and ambulatory centers find, engage, and retain patients in need of care,” said Charles Martin, Jr., Founder and Chairman of Martin Ventures. “It’s always been the vision of Trilliant to leverage data and technology to bring together strategy and execution. The Trilliant analytics and data science platform provides insights to build a growth strategy. The Trilliant technology products, including Customer Relationship Management (CRM), Lead Management (LM), Physician Relationship Management (PRM), and Employer Relationship Management (ERM), provide the ability to execute on those strategies and insights.”
“We are excited to add Noro-Moseley Partners to our already impressive list of investors and partners,” said Hal Andrews, CEO of Trilliant Health. “In an environment of relentless reimbursement cuts, rising expenses, and increasing competition, healthcare providers need strategies to find the most efficient and effective solutions for growth more than ever. Trilliant is that growth partner for health systems and other healthcare providers. This capital will help us achieve our goals.”
About Trilliant Health
Trilliant Health is an analytics company that empowers intelligent patient acquisition. By synthesizing all-payer claims, household, and patient-generated data, Trilliant Health provides a comprehensive view into market dynamics that enables healthcare providers to find the most efficient and effective solutions for growth in their markets. For more information, please visit trillianthealth.com.
# # #